Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Cyclooxygenase inhibition in mice heightens adaptive- and innate-type responses against inhaled protease allergen and IL-33.

Maruyama N, Takai T, Kamijo S, Suchiva P, Ohba M, Takeshige T, Suzuki M, Hara M, Matsuno K, Harada S, Harada N, Nakae S, Sudo K, Okuno T, Yokomizo T, Ogawa H, Okumura K, Ikeda S.

Allergy. 2019 Apr 21. doi: 10.1111/all.13831. [Epub ahead of print] No abstract available.

PMID:
31006115
2.

The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation.

Toki S, Goleniewska K, Reiss S, Zhou W, Newcomb DC, Bloodworth MH, Stier MT, Boyd KL, Polosukhin VV, Subramaniam S, Peebles RS Jr.

Thorax. 2016 Jul;71(7):633-45. doi: 10.1136/thoraxjnl-2015-207728. Epub 2016 Apr 12.

3.

Allergen-induced Increases in Sputum Levels of Group 2 Innate Lymphoid Cells in Subjects with Asthma.

Chen R, Smith SG, Salter B, El-Gammal A, Oliveria JP, Obminski C, Watson R, O'Byrne PM, Gauvreau GM, Sehmi R.

Am J Respir Crit Care Med. 2017 Sep 15;196(6):700-712. doi: 10.1164/rccm.201612-2427OC.

PMID:
28422515
4.

IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation.

Kamijo S, Takeda H, Tokura T, Suzuki M, Inui K, Hara M, Matsuda H, Matsuda A, Oboki K, Ohno T, Saito H, Nakae S, Sudo K, Suto H, Ichikawa S, Ogawa H, Okumura K, Takai T.

J Immunol. 2013 May 1;190(9):4489-99. doi: 10.4049/jimmunol.1201212. Epub 2013 Apr 1.

5.

Subcutaneous Allergic Sensitization to Protease Allergen Is Dependent on Mast Cells but Not IL-33: Distinct Mechanisms between Subcutaneous and Intranasal Routes.

Kamijo S, Suzuki M, Hara M, Shimura S, Ochi H, Maruyama N, Matsuda A, Saito H, Nakae S, Suto H, Ichikawa S, Ikeda S, Ogawa H, Okumura K, Takai T.

J Immunol. 2016 May 1;196(9):3559-69. doi: 10.4049/jimmunol.1500717. Epub 2016 Mar 21.

6.

Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice.

Karras JG, Crosby JR, Guha M, Tung D, Miller DA, Gaarde WA, Geary RS, Monia BP, Gregory SA.

Am J Respir Cell Mol Biol. 2007 Mar;36(3):276-85. Epub 2006 Sep 21.

PMID:
16990616
7.

Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.

van Rijt L, von Richthofen H, van Ree R.

Semin Immunopathol. 2016 Jul;38(4):483-96. doi: 10.1007/s00281-016-0556-2. Epub 2016 Mar 10. Review.

8.

Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses.

Hristova M, Habibovic A, Veith C, Janssen-Heininger YM, Dixon AE, Geiszt M, van der Vliet A.

J Allergy Clin Immunol. 2016 May;137(5):1545-1556.e11. doi: 10.1016/j.jaci.2015.10.003. Epub 2015 Nov 17.

9.

Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness--a murine model.

Hamelmann E, Tadeda K, Oshiba A, Gelfand EW.

Allergy. 1999 Apr;54(4):297-305. Review.

PMID:
10371087
10.

Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.

Hacha J, Tomlinson K, Maertens L, Paulissen G, Rocks N, Foidart JM, Noel A, Palframan R, Gueders M, Cataldo DD.

Am J Respir Cell Mol Biol. 2012 Nov;47(5):709-17. doi: 10.1165/rcmb.2012-0031OC. Epub 2012 Aug 16.

11.

Fibrinogen cleavage products and Toll-like receptor 4 promote the generation of programmed cell death 1 ligand 2-positive dendritic cells in allergic asthma.

Cho M, Lee JE, Lim H, Shin HW, Khalmuratova R, Choi G, Kim HS, Choi WS, Park YJ, Shim I, Kim BS, Kang CY, Kim JO, Tanaka S, Kubo M, Tung HY, Landers CT, Corry DB, Kheradmand F, Chung Y.

J Allergy Clin Immunol. 2018 Aug;142(2):530-541.e6. doi: 10.1016/j.jaci.2017.09.019. Epub 2017 Oct 14.

PMID:
29038008
12.

The IL-33/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus-derived serine protease-like protein D.

Teufelberger AR, Nordengrün M, Braun H, Maes T, De Grove K, Holtappels G, O'Brien C, Provoost S, Hammad H, Gonçalves A, Beyaert R, Declercq W, Vandenabeele P, Krysko DV, Bröker BM, Bachert C, Krysko O.

J Allergy Clin Immunol. 2018 Feb;141(2):549-559.e7. doi: 10.1016/j.jaci.2017.05.004. Epub 2017 May 19.

PMID:
28532656
13.

An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects.

Wood LJ, Sehmi R, Gauvreau GM, Watson RM, Foley R, Denburg JA, O'byrne PM.

Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1457-63.

PMID:
10228111
14.
15.

CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma.

Ferrini ME, Hong S, Stierle A, Stierle D, Stella N, Roberts K, Jaffar Z.

Allergy. 2017 Jun;72(6):937-947. doi: 10.1111/all.13107. Epub 2017 Jan 23.

16.

Alveolar macrophages play a key role in cockroach-induced allergic inflammation via TNF-α pathway.

Kim JY, Sohn JH, Choi JM, Lee JH, Hong CS, Lee JS, Park JW.

PLoS One. 2012;7(10):e47971. doi: 10.1371/journal.pone.0047971. Epub 2012 Oct 19.

17.

TH2 and TH1 lung inflammation induced by airway allergen sensitization with low and high doses of double-stranded RNA.

Jeon SG, Oh SY, Park HK, Kim YS, Shim EJ, Lee HS, Oh MH, Bang B, Chun EY, Kim SH, Gho YS, Zhu Z, Kim YY, Kim YK.

J Allergy Clin Immunol. 2007 Oct;120(4):803-12. Epub 2007 Jul 5.

PMID:
17610940
18.

Innate and adaptive type 2 immunity in lung allergic inflammation.

Kubo M.

Immunol Rev. 2017 Jul;278(1):162-172. doi: 10.1111/imr.12557. Review.

PMID:
28658559
19.

Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation.

Halim TY, Krauss RH, Sun AC, Takei F.

Immunity. 2012 Mar 23;36(3):451-63. doi: 10.1016/j.immuni.2011.12.020. Epub 2012 Mar 15.

20.

Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures.

Gold MJ, Antignano F, Halim TY, Hirota JA, Blanchet MR, Zaph C, Takei F, McNagny KM.

J Allergy Clin Immunol. 2014 Apr;133(4):1142-8. doi: 10.1016/j.jaci.2014.02.033.

PMID:
24679471

Supplemental Content

Support Center